In a seminal paper, Ji et al. used a mutant KRAS-driven model of mouse lung cancer to show that LKB1 inactivation stimulated the growth of tumors of various histotypes with vigorously strong shortened latency to growth and to metastasis development compared to the LKB1-wild-type (WT) counterpart. Here, KRAS is linked to lung carcinoma.